In line with this, it was recently shown that B lymphoma-derived small EVs enriched with CD39 and CD73 are able to hydrolyse ATP released from chemotherapy-treated cancer cells into adenosine [116] which is known to affect cancer immune response causing M2-like macrophages polarization and inhibit T cell activity and proliferation [117]. The gene discussed is NT5E; the disease is cancer.